100 QUESTIONS IN CARDIOLOGY

(Michael S) #1

pregnancy
contraindications 119988
dilated cardiomyopathy 119944 – – 55
valve disease 119966 – – 77
Primary Angioplasty in Myocardial
Infarction (PAMI) trial 55
Probucol 48
propafenone, paroxysmal atrial
fibrillation 133
propranolol, hypertension, effect on
mortality 10
prourokinase 53
PTCA seepercutaneous transluminal
coronary angioplasty
pulmonary autograft (Ross) procedure
9922 – – 33


QT intervals: long QT syndrome
117755 – – 66 , 177


radial artery grafts 77
RADIANCE Study 116
radiofrequency ablation,
supraventricular tachycardia
113377 – – 88
Randomized Aldactone Evaluation
Study (RALES) 116
resins seeanion-exchange resins
reteplase (rPA) 53
retinopathy, diabetic, thrombolytic
therapy and 57–8
Romano–Ward syndrome 175
Ross procedure 9922 – – 33


SAVE study 111–12
Scandinavian Simvastatin Survival
Study (4S) 18
screening
long QT syndrome 175
secondary causes of hypertension 55 – – 66
serology, dilated cardiomyopathy
investigation 109
SHOCK trial 68
single-photon emission computed
tomography,^201 T1 (T1SPECT),
assessment of
myocardial viability 33–4
sodium nitroprusside, hypertensive
encephalopathy 15–16
SOLVD prevention trial 111
sotalol, paroxysmal atrial fibrillation
133
spironolactone, heart failure 112
statins
coronary heart disease
prevention 17
treatment 18


drug interactions 23
dyslipidaemia 20
myocardial infarction patients 64
side effects 22
streptokinase (SK) 51
acute myocardial infarction 52–3
stroke
patent foramen ovale and 155
prevention, atrial fibrillation
patients 135
risk
assessment in atrial fibrillation
patient 114499 – – 5500
blood pressure lowering and 7–8
cardiac surgery 70–1
following valve replacement 9944
hypertension and 1
thrombolytic therapy and 57
transthoracic and transoesophageal
echocardiography 115533 – – 44
sudden death
hypertrophic cardiomyopathy, risk
factors 101–2, 104
prevention using implantable
cardiac defibrillator 184
VT stimulation studies 182–3
young athletes 177
investigation of relatives 117777 – – 88
sulphonylureas, following CABG 8822 – – 33
supraventricular tachycardia (SVT),
radiofrequency ablation 113377 – – 88
surgery
bypass seecoronary artery bypass
graft
cardiac
myocardial infarction risk 7700 – – 11
stopping aspirin before 8866
elective, anticoagulation of
mechanical heart valve patient
220022 – – 33
non-cardiac
cardiac risk factors 221122 – – 1155
pre-operative investigations
221100 – – 1111
syncope
investigation 115577 – – 6600
implantable loop recorder 116622
tilt test 116600
24-hour ambulatory monitoring
116611 – – 33
vasovagal, management 159, 160

tacrolimus, transplant patients 129,
130
thallium scanning 3311 – – 22 , 210, 212
Thrombolysis in Myocardial
Infarction (TIMI) IIIB trial 45

Index 221

Free download pdf